General Clinical Study of AJG555 in Pediatric Patients with Chronic Constipation
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2017
At a glance
- Drugs AJG 555 (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors EA Pharma
- 01 Nov 2017 Actual end date kept as per NCT
- 05 Oct 2017 Status changed from active, no longer recruiting to completed.
- 19 May 2017 Planned primary completion date changed from 1 May 2017 to 1 Jun 2017.